Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The value of MYB as a prognostic marker for adenoid cystic carcinoma: Meta‐analysis

13 Feb 2019

Abstract excerpt

The aim of this meta-analysis is to evaluate myeloblastosis (MYB) as a prognostic marker for patients with adenoid cystic carcinoma (ACC) with respect to MYB gene fusion, MYB protein expression, and tumor sites. We comprehensively searched PubMed, Embase, Web of Science, and Cochrane libraries. Ten studies concerning the prognostic comparisons between MYB positivity and negativity were included. The combined...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ear and Head Tumors
Share to Salivary Gland Tumors Diagnosis and Treatment
Share to Vascular Malformations and Hemangiomas

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30759319
DOI: 10.1002/hed.25597

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The value of MYB as a prognostic marker for adenoid cystic carcinoma: Meta‐analysisPMID 30759319Read ↗

Rearrangements, Expression, and Clinical Significance of MYB and MYBL1 in Adenoid Cystic Carcinoma: A Multi-Institutional StudySemantic proximity Read ↗

A unifying gene signature for adenoid cystic cancer identifies parallel MYB-dependent and MYB-independent therapeutic targetsSemantic proximity Read ↗

Adenoid cystic carcinoma: emerging role of translocations and gene fusionsSemantic proximity Read ↗

Alternative MYB Promoter Activity Is a Potential Prognostic Biomarker in Head and Neck Adenoid Cystic CarcinomaSemantic proximity Read ↗

Development and Characterization of MYB-NFIB Fusion Expression in Adenoid Cystic CarcinomaSemantic proximity Read ↗

Adenoid cystic carcinoma: current therapy and potential therapeutic advances based on genomic profilingSemantic proximity Read ↗

Clinical significance of Myb protein and downstream target genes in salivary adenoid cystic carcinomaSemantic proximity Read ↗

The incidence of MYB gene breaks in adenoid cystic carcinoma of the salivary glands and its prognostic significance.Semantic proximity Read ↗

Adenoid cystic carcinoma: A review of recent advances, molecular targets, and clinical trials.Semantic proximity Read ↗

MYB alternative promoter activity is increased in adenoid cystic carcinoma metastases and is associated with a specific gene expression signatureSemantic proximity Read ↗

Comprehensive analysis of the MYB-NFIB gene fusion in salivary adenoid cystic carcinoma: Incidence, variability, and clinicopathologic significance.Semantic proximity Read ↗

Adenoid Cystic Carcinoma of the Lacrimal Gland: MYB Gene Activation, Genomic Imbalances, and Clinical CharacteristicsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.